Aeterna Zentaris
AEZS
#10128
Rank
โ‚น1.61 B
Marketcap
โ‚น525.90
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): -โ‚น170.14

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is -โ‚น188.38. In 2022 the company made an earnings per share (EPS) of -โ‚น430.28 a decrease over its 2021 EPS that were of -โ‚น167.33.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-โ‚น170.14
2022-โ‚น430.28157.14%
2021-โ‚น167.33-41.48%
2020-โ‚น285.93-64.46%
2019-โ‚น804.48-240%
2018โ‚น574.63-122.32%
2017-โ‚น2,574-53.53%
2016-โ‚น5,539-86.71%
2015-โ‚น41,695-35.21%
2014-โ‚น64,358-216.67%
2013โ‚น55,164-123.3%
2012-โ‚น2,36,746-40.8%
2011-โ‚น3,99,938-6.45%
2010-โ‚น4,27,520-27.91%
2009-โ‚น5,93,012-61.61%
2008-โ‚น15,44,58983.61%
2007-โ‚น8,41,249-195.31%
2006โ‚น8,82,622178.26%
2005โ‚น3,17,192-330%
2004-โ‚น1,37,910-80.05%
2003-โ‚น6,91,26617.78%
2002-โ‚น5,86,921515.93%
2001-โ‚น95,291-68.6%
2000-โ‚น3,03,503119.62%
1999-โ‚น1,38,193-3.63%
1998-โ‚น1,43,404

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
โ‚น676.68-459.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚น189.87-200.79%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น273.06-244.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น33.10-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
โ‚น449.59-338.66%๐Ÿ‡บ๐Ÿ‡ธ USA